b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31129807</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>17</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>05</Month>\n            <Day>26</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">2008-2231</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>27</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Jun</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences</Title>\n                <ISOAbbreviation>Daru</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Safety and efficacy of hydroxytyrosol-based formulation on skin inflammation: in vitro evaluation on reconstructed human epidermis model.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>283-293</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s40199-019-00274-3</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Atopic dermatitis is a multifactorial immune-mediated skin disorder characterized by an alteration of epidermal barrier function and onset of skin lesions, which range from mild erythema to severe lichenification. Treatment consists in hydration with possible use of topical or immunomodulatory corticosteroids, which, however sometimes showed side effects. Recently, the interest in natural compounds has grown significantly and among these, hydroxytyrosol (HT) plays a pivotal role due to its strong and well-known anti-inflammatory activity.</AbstractText>\n                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study was to investigate the safety and efficacy of Fenolia\xc2\xae Eudermal Cream 15 (HT-based formulation) on epidermal barrier impaired as consequence of skin injury.</AbstractText>\n                <AbstractText Label="METHODS" NlmCategory="METHODS">Whit this purpose, morphologic and structural as well as anti-inflammatory evaluations, after treatment with pro-inflammatory mediators (PBS 1 X and LPS) and HT-based formulation on reconstructed human epidermis (RHE) were carried out by qualitative (hematoxylin/eosin- and immunostaining) and quantitative (MTT assay, IL-1\xce\xb1 and IL-8 release by ELISA) techniques. Furthermore, HT absorption through the epidermal barrier was evaluated by RP-LC-DAD analysis.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A rise in the thickness of the epidermis as well as an appropriate maturation and protein expression (Loricrin, Fillagrin, E-Cadherin and Cytokeratins 5&amp;6) were detected in treated RHE samples. In particular, the HT-based formulation was found to stimulate cell proliferation, as evidenced by the significant increase in Ki67 expression, which suggests the involvement of repair mechanisms, increasing epithelial regeneration and differentiation and improving the epidermal barrier effect. Furthermore, HT-based formulation showed a statistically significant anti-inflammatory activity by reducing both IL-1\xce\xb1 and IL-8 release by RHE tissues, greater than the reference drug dexamethasone. Finally, excellent transcutaneous absorption values were found for HT, demonstrating how this new formulation increases the availability of the bioactive compound.</AbstractText>\n                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In light of these results, Fenolia\xc2\xae Eudermal Cream 15 could be an effective agent to counteract atopic dermatitis. Graphical abstract Safety and efficacy of hydroxytyrosol-based formulation on skin inflammation: in vitro evaluation on reconstructed human epidermis model.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Smeriglio</LastName>\n                    <ForeName>Antonella</ForeName>\n                    <Initials>A</Initials>\n                    <Identifier Source="ORCID">http://orcid.org/0000-0002-9756-304X</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Via Ferdinando Stagno d\'Alcontres, 31, Viale SS. Annunziata, 98166, Messina, ME, Italy. asmeriglio@unime.it.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Fondazione Prof. A. Imbesi, University of Messina, Piazza Pugliatti, 1, Messina, ME, Italy. asmeriglio@unime.it.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Denaro</LastName>\n                    <ForeName>Marcella</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Via Ferdinando Stagno d\'Alcontres, 31, Viale SS. Annunziata, 98166, Messina, ME, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Fondazione Prof. A. Imbesi, University of Messina, Piazza Pugliatti, 1, Messina, ME, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mastracci</LastName>\n                    <ForeName>Luca</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Anatomic Pathology, Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Viale Benedetto XV, 6, 16132, Genoa, GE, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, Genoa, GE, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Grillo</LastName>\n                    <ForeName>Federica</ForeName>\n                    <Initials>F</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Anatomic Pathology, Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Viale Benedetto XV, 6, 16132, Genoa, GE, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, 10, Genoa, GE, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cornara</LastName>\n                    <ForeName>Laura</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Earth, Environment and Life Sciences, University of Genoa, Corso Europa 26, 16132, Genoa, GE, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Shirooie</LastName>\n                    <ForeName>Samira</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Pharmaceutical Sciences Research Center, Kermanshah University of Medical Sciences, Shahid Beheshti Boulevard, Kermanshah, 6715847141, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Nabavi</LastName>\n                    <ForeName>Seyed Mohammad</ForeName>\n                    <Initials>SM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Nosrati Alley, Sheikh Bahai South Avenue, Mollasadra St, Vanak Sq, Tehran, 1435916471, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Trombetta</LastName>\n                    <ForeName>Domenico</ForeName>\n                    <Initials>D</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Via Ferdinando Stagno d\'Alcontres, 31, Viale SS. Annunziata, 98166, Messina, ME, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>26</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Switzerland</Country>\n            <MedlineTA>Daru</MedlineTA>\n            <NlmUniqueID>101125969</NlmUniqueID>\n            <ISSNLinking>1560-8115</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>10597-60-1</RegistryNumber>\n                <NameOfSubstance UI="C005975">3,4-dihydroxyphenylethanol</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>ML9LGA7468</RegistryNumber>\n                <NameOfSubstance UI="D010626">Phenylethyl Alcohol</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000287" MajorTopicYN="N">Administration, Topical</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003872" MajorTopicYN="N">Dermatitis</DescriptorName>\n                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>\n                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004339" MajorTopicYN="N">Drug Compounding</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004817" MajorTopicYN="N">Epidermis</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n                <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010626" MajorTopicYN="N">Phenylethyl Alcohol</DescriptorName>\n                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012869" MajorTopicYN="N">Skin Absorption</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D063465" MajorTopicYN="N">Skin Cream</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Anti-inflammatory effect</Keyword>\n            <Keyword MajorTopicYN="N">Atopic dermatitis</Keyword>\n            <Keyword MajorTopicYN="N">Histology and immunohistochemistry</Keyword>\n            <Keyword MajorTopicYN="N">Hydroxytyrosol</Keyword>\n            <Keyword MajorTopicYN="N">In vitro reconstructed human epidermis</Keyword>\n            <Keyword MajorTopicYN="N">Semi-solid formulation</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>05</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>09</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>18</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31129807</ArticleId>\n            <ArticleId IdType="doi">10.1007/s40199-019-00274-3</ArticleId>\n            <ArticleId IdType="pii">10.1007/s40199-019-00274-3</ArticleId>\n            <ArticleId IdType="pmc">PMC6593001</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Curr Pharm Des. 2001 Jul;7(10):933-50</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11472248</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Cancer. 1992;28A(8-9):1452-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">1387543</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Complement Ther Med. 2003 Dec;11(4):226-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15022655</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Microbiol Infect. 2005 Feb;11(2):160-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15679495</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Agric Food Chem. 2007 May 16;55(10):4139-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17439139</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Invest Dermatol. 2008 May;128(5):1067-70</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18408746</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cosmet Sci. 2004 Aug;26(4):173-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18494924</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Dermatol. 2009 Mar-Apr;27(2):159-65</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19167997</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Biol Pharm Bull. 2009 Apr;32(4):578-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19336887</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Mol Sci. 2010 Feb 02;11(2):458-79</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20386648</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Eur Acad Dermatol Venereol. 2011 Jan;25(1):12-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20569298</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Sci Pharm. 2010;78(2):133-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21179340</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Alzheimer Res. 2011 Aug;8(5):543-51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21605049</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Planta Med. 2011 Nov;77(17):1890-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21830187</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Nat Prod. 2011 Nov 28;74(11):2377-81</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22014120</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Korean Med Sci. 2012 Nov;27(11):1327-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23166413</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Anticancer Res. 2012 Dec;32(12):5371-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23225439</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Pharm. 2013 Feb 28;444(1-2):109-19</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23337632</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Drugs Dermatol. 2013 Sep;12(9 Suppl):s128-32</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24002161</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drug Discov Today. 2014 Apr;19(4):373-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24246683</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacogn Rev. 2014 Jan;8(15):52-60</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24600196</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Expert Rev Clin Immunol. 2014 May;10(5):593-619</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24678812</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Allergy Asthma Immunol Res. 2014 Jul;6(4):276-87</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24991450</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2014 Nov 14;9(11):e113143</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25396426</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharm Pharmacol. 2015 Jul;67(7):900-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25645286</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>G Ital Dermatol Venereol. 2016 Aug;151(4):403-11</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25658440</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cytokine. 2015 Nov;76(1):25-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26185894</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Evid Based Complement Alternat Med. 2015;2015:908493</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26693247</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Dermatol Ther (Heidelb). 2017 Mar;7(1):1-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28025775</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Investig Allergol Clin Immunol. 2017;27(2):78-88</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28071589</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Histochem Cell Biol. 2017 Jul;148(1):95-101</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28285337</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Mol Sci. 2017 Apr 11;18(4):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28398235</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Dermatol Res. 2017 Aug;309(6):443-452</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28432437</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oxid Med Cell Longev. 2017;2017:2473495</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28855976</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Mol Sci. 2017 Oct 25;18(11):null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29068387</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Pediatr. 2018 Feb;30(1):161-168</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29176352</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>G Ital Dermatol Venereol. 2018 Apr;153(2):133-145</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29237258</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Dermatol Sci. 2018 Mar;89(3):213-218</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29248403</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Inflamm Regen. 2017 Jun 5;37:14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29259713</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Medicines (Basel). 2018 Jan 23;5(1):null</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29360770</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Core Evid. 2018 Feb 23;13:13-20</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29503598</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Eur Acad Dermatol Venereol. 2018 Jun;32(6):850-878</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29878606</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Dermatol Ther (Heidelb). 2018 Dec;8(4):527-538</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30182182</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'